Close Menu

NEW YORK – A partnership between an established infectious disease diagnostics team and a high-throughput laboratory with a pedigree in sports drug testing has led to a 10,000 per day increase in COVID-19 testing capacity in the Los Angeles area. The partners, Curative and KorvaLabs, set up a designated COVID-19 lab in less than one month and have received Emergency Use Authorization from the US Food and Drug Administration for a lab-developed test.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new study finds that three dimensional facial scans may be able to aid in diagnosing rare genetic diseases.

The Lancet and the New England Journal of Medicine have retracted two COVID-19 papers due to concerns about the data used in their analyses.

Lawmakers plan to introduce a bill that aims to prevent the theft of US-funded research, according to the Wall Street Journal.

In Science this week: analysis of ancient Caribbean islanders' genomes suggests at least three waves of migration into the region,  DNA barcoding of microbial spores, and more.

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.